Fact Sheet for Healthcare Providers: CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay: July 2, 2020

Details

• Corporate Authors:
  Centers for Disease Control and Prevention (U.S.)
• Description:
  This Fact Sheet informs you of the significant known and potential risks and benefits of the emergency use of the Centers for Disease Control and Prevention’s (CDC’s) Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay.
  
  Testing is to be conducted on specimens from individuals suspected of respiratory viral infection consistent with COVID-19 by a healthcare provider. Symptoms of respiratory viral infection due to SARS- CoV-2 and influenza can be similar.
  
  This test is to be performed using respiratory specimens collected from individuals suspected of respiratory viral infection consistent with COVID-19 by a healthcare provider.
  
  Fact-Sheet-for-Healthcare-Providers-final.pdf
  
  
• Subjects:
  Communicable Disease Control Coronavirus Infections/diagnosis COVID-19/diagnosis Mass Screening Public Health Surveillance Reverse Transcriptase Polymerase Chain Reaction
• Document Type:
  Pamphlet (or booklet)
• Genre:
  Fact Sheet
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha-512:6978a134c4a19c83f1e270ef52cd6792483b47784f99cb33da0f76e7af23ed30f80e9a63a4a46e7c9f6ebb9dff7029330a658c430ddf4657efa8b77ccb0fc14a
• Download URL:
  https://stacks.cdc.gov/view/cdc/91409/cdc_91409_DS1.pdf
• File Type:
  [PDF - 155.02 KB ]